SciELO - Scientific Electronic Library Online

 
vol.94 issue6Alkaline phosphatase isoenzymes in plasma of chagasic and healthy pregnant womenStudies on the effectiveness of diarylheptanoids derivatives against Leishmania amazonensis author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

Related links

Share


Memórias do Instituto Oswaldo Cruz

On-line version ISSN 1678-8060

Mem. Inst. Oswaldo Cruz vol.94 n.6 Rio de Janeiro Nov./Dec. 1999

http://dx.doi.org/10.1590/S0074-02761999000600014 

Predictive Value of the Acid Fast Smear for Detection of Mycobacterium tuberculosis in Respiratory Specimens in a Reference Center of HIV/Aids in Rio de Janeiro, Brazil

Vol. 94(6): 787-790, Nov./Dec. 1999

Marcus B Conde, Cesar M Figueira*, Renata Moraes*, Leila S Fonseca*,
Kathy DeRiemer**, Afranio L Kritski/+

Unidade de Pesquisa *Laboratório de Bacteriologia em Tuberculose, Serviço de Pneumologia, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Av. Brigadeiro Trompowski s/n°, 4° andar, Ilha do Fundão, 21941-590 Rio de Janeiro, RJ, Brasil **Division of Public Health Biology & Epidemiology, University of California, Berkeley, USA

In order to evaluate the predictive value of acid fast bacilii (AFB) smear for the diagnosis of Mycobacterium tuberculosis in respiratory specimens in a setting with a high prevalence of Aids and an unknown prevalence of nontuberculous mycobacteria (NTM), we retrospectively examined specimens cultured for mycobacteria between 1 September 1993 and 30 September 1994 and medical records of patients with positive culture in a General Hospital, Aids reference in Rio de Janeiro, Brazil. Seventy three per cent (1517/2077) of samples were respiratory specimens and mycobacteria were recovered from 20.6% (313/1517) of these. M. tuberculosis was identified in 94.2% (295/313) and NTM in 5.8% (18/313). The yield of positive AFB smear and of positive culture was 6.1% (93/1517) and 20.6% (313/1517), respectively. The positive predictive value (PPV) of AFB for M. tuberculosis was 98.4% in expectorated sputum and 96.4% in bronchoalveolar lavage. Forty four percent (130/295) of specimens with positive culture for M. tuberculosis and 66.7% (12/18) for NTM were from patients HIV positive. The conclusion was that in our study population, the PPV of AFB for M. tuberculosis in respiratory specimens was high and the prevalence of NTM was low despite the high prevalence of HIV positive.

Key words: Mycobacterium tuberculosis - acid fast smear - non tuberculous mycobacteria - HIV/Aids

linha2.jpg (2100 bytes)

Before the acquired immunodeficiency syndrome (Aids) epidemic, infections with Mycobacterium tuberculosis (M.tb) and nontuberculous mycobacteria (NTM) were recognized as an uncommon cause of disease in developed countries (Horsburgh Jr 1991). Where infection with the HIV became prevalent, the incidence of mycobacteria increased (Horsburgh Jr 1991, Kritski et al. 1995, Raviglione et al. 1995). Although the impact of HIV infection on the incidence of M.tb has been well described in developing countries, its impact on the incidence and prevalence of NTM has not (Barreto et al. 1993, Raviglione et al. 1995, Shafer & Edlin 1996). Detection of acid fast bacilli (AFB) in respiratory specimens is the diagnostic approach for the diagnosis of pulmonary tuberculosis (TB), as recommended by the World Health Organization (WHO 1993). Since NTM are indistinguishable from M.tb in AFB smear, the value of positive AFB in respiratory specimens for predicting pulmonary TB is unclear, especially where the prevalence of NTM is unknown. In Rio de Janeiro, Brazil, the prevalence of co-infection of HIV and disseminated mycobacterial disease is expected to be high (Grinsztejn et al. 1997, Kritski et al. 1998). We therefore conducted a study in a General Hospital in Rio de Janeiro with a high prevalence of HIV and mycobacterial infections. We retrospectively examined specimens cultured for mycobacteria and medical records of cases with positive culture for mycobacterium and the predictive value of AFB smear for M.tb was determined.

linha2.jpg (2100 bytes)

bul1.gif (879 bytes)  MATERIALS AND METHODS

bul1.gif (879 bytes)  RESULTS

bul1.gif (879 bytes)  DISCUSSION

bul1.gif (879 bytes)  ACKNOWLEDGEMENTS

bul1.gif (879 bytes)  REFERENCES

linha2.jpg (2100 bytes)

bul1.gif (879 bytes)  MATERIALS AND METHODS

The medical records of patients from whom clinical specimens were culture positive for mycobacteria were reviewed. The clinical specimens were analyzed by the Bacteriology Laboratory of the Clementino Fraga Filho Hospital of Rio de Janeiro Federal University, an Aids Reference Center. All materials were collected, cultured and smeared for AFB between 1 September 1993 and 30 September 1994. During this period there were no changes in the laboratory methods used for the culture of mycobacteria. The laboratory methods for processing specimens, for cultures and for AFB smears followed standard methods (Kent & Kubica 1985). The respiratory specimens were decontaminated with 4% NaOH. All fluids except blood were plated onto Löwestein Jensen medium and smeared for AFB with the Ziehl Neelsen technique after sedimentation at 3000 x g. For blood specimens, only culture in Löwestein Jensen medium was performed. Cultures were reviewed weekly for growth, and those cultures showing no growth were incubated for eight weeks before they were discarded. All specimens that were culture positive for mycobacteria were tested to distinguish M.tb from NTM and organisms belonging to M. avium complex (MAC) were identified. HIV antibody counseling and testing was offered to those patients with clinical symptoms or risk factors for Aids. The serum sample was initially screened for HIV antibody by enzyme-linked immunosorbent assay (Orth Diagnostic Systems, Raritan, NJ, USA). Repeatedly reactive samples were submitted to Western blot analysis. Interpretation of Western blot results followed the manufacturer's instruction.

linha2.jpg (2100 bytes)

bul1.gif (879 bytes)  RESULTS

Mycobacteria was recovered from 17.5% (363/2077) of all specimens cultured. We excluded 38 AFB smear positive specimens which were either culture negative (n = 27) or contaminated (n = 11). Among those specimens that were culture-positive, M.tb was identified in 93.1% (338/363) and NTM in 6.9% (25/363). The 338 specimens of M.tb refer to 294 patients and the 25 specimens of NTM to 20 patients. Seventy three per cent (1517/2077) of samples cultured were respiratory specimens. Mycobacteria was recovered from 20.6% (313/1517) respiratory specimens, with 65.4% (205/313) in expectorated sputum, 32.6% (102/313) in bronchoalveolar lavage (BAL) and 2% (6/313) in bronchial aspirate. M.tb was identified in 94.2% (295/313) and NTM in 5.8% (18/313). M.tb was isolated in 93.6% (192/205) of expectorated sputum and in 95% (97/102) of BAL while NTM was isolated in 6.4% (13/205) and 5% (5/102), respectively (Table). Among NTM, 27% (5/18) were identified as avium complex and the others were not identified. The rate of smear positivity calculated for expectorated sputum was 32.2% (62/192) for specimens with M.tb and 7.7% (1/13) in specimens with NTM (Table). The rate of AFB positivity for M.tb in expectored sputum from HIV positive patients was 29.7% (25/84) and in patients with HIV negative or without HIV tested was 34.2% (37/108). The rates of smear positivity for BAL were 27.8% (27/97) for M.tb and 20% (1/5) for NTM (Table). The rate of AFB positivity in BAL from HIV positive patients was 23.8% (10/42) and in patients with HIV negative or without HIV tested was 30.9% (17/55). The positive predictive value (PPV) of AFB for M.tb in all cultures positive for mycobacteria was 98.4% (62/63) in expectorated sputum and 96.4% (27/28) in BAL. The yield of positive AFB during the period of the study was 6.6% (63/952) for sputum specimens and 5.3% (27/505) for BAL specimens while the yield of positive culture was 21.5% (205/952) and 19.2% (97/505), respectively.

Forty four percent (130/294) of patients with positive culture for M.tb and 60% (12/20) with NTM were HIV positive. Among the 18 patients that have respiratory specimens culture-positive for NTM, 66.6% (12/18) were male, with an age range between 25 and 53 years (median 37.1). In 16.6% (3/18) of these patients, disseminated infection were confirmed as well in the two remaining patients with NTM infection (four blood specimens and one bone marrow specimen). The five cases with disseminated disease were HIV positive.

linha2.jpg (2100 bytes)

bul1.gif (879 bytes)  DISCUSSION

In this study, the prevalence of 6.9% culture positive specimens for NTM was lower than that described in the United States and Europe (Good & Snider 1983, Horsburgh Jr 1991, WHO 1993, Yajko et al. 1994). Yajko et al. (1994) reported 51% NTM among 2139 mycobacteria cultured in San Francisco. This figure was higher than the 35% cases of NTM found in 1983, prior to the HIV epidemic, in all mycobacteria isolated in the United States (Good & Snider 1983).

In São Paulo, Brazil, 0.87% (23/2628) of Aids patients had disseminated disease due infection with NTM in a study performed from 1990-1992 (Barreto et al. 1992). In Rio de Janeiro, bacillemia was detected in 30 of 42 patients with Mycobacterium isolated (Grinztejn et al. 1997). MAC was detected in 11 (28.2%) and M.tb in 19 (71.8%). Unfortunately, in those two prospective studies no data regarding the yield of AFB and culture in respiratory specimens were showed. In our retrospective study, the occurrence of disseminated mycobaterial disease was lower because we focused mainly on analyses respiratory specimens.

Before the Aids epidemic, 40 to 70% of patients with M.tb isolated in culture had positive AFB smears (Toman 1979). Among patients with Aids, these figures tend to be lower (WHO 1993, Shafer & Edlin 1996). In our General Hospital, an Aids reference center, the smear positivity among the culture positive specimens for M.tb was lower in expectorated sputum (32%) and in brochoalveolar lavage (27%). Among all specimens of sputum evaluated, the yield of AFB in the sputum was 6.6% and of culture for M.tb, 21.5%. These data suggest that culture is indicated for diagnosis of TB in these patients, mainly in a hospital with a high prevalence of co-infection TB/HIV. These results are different from those found by Elliot et al. (1990) in Zambia, where the yield of AFB and culture was quite similar to that of clinical diagnosis of tuberculosis.

Although Klein et al. (1989) has reported a smear-positivity rate of sputum specimens from HIV positive patients lower than the rate from individuals not infected with HIV, Yajko et al. (1994) and Theuer et al. (1990) found no difference beetwen smear-positivity rate of sputum specimens of these two groups of patients. In our study, the smear positivity rate of sputum and BAL specimens from HIV positive patients tend to be lower than that observed among specimens from patients HIV negative and those with no HIV test performed.

We found AFB positive in 11% (2/18) of respiratory specimens which were culture positive for NTM, even with the high prevalence of cases with positive HIV. The prevalence of AFB positivity among NTM seems to vary according to the region studied. In the United States, 6% (15/232) of the expectoraded sputum specimens that were culture positive for MAC were AFB positive (Yajko et al. 1994). In Hong Kong, 86% of sputum specimens from 28 patients with progressive pulmonary disease due to NTM had AFB positive smears, whereas only 2% of 134 patients with transient isolation of NTM or without evidence of progressive pulmonary disease (contaminated sputum specimens) had AFB positive smears (Hosker et al. 1995).

Yajko et al. (1994) reported that the PPV of the AFB smear for M.tb was high (92%) for sputum and relatively low (71%) for BAL specimens. In our study, the PPV of the AFB for M.tb in expectorated sputum (98.4%) and in BAL specimens (96.4%) remained as high as the level reported before the Aids epidemic (82-100%) (Strumph et al. 1979, Murray et al. 1980).

The data presented in this study demonstrate that in a setting with a high prevalence of Aids, the PPV of AFB for M.tb in respiratory specimens from expectorated sputum or BAL is high and the prevalence of NTM is low. Our data also demonstrate the high sensitivity show the importance in these specimens of culture for the tuberculosis diagnosis in this setting.

linha2.jpg (2100 bytes)

bul1.gif (879 bytes)  ACKNOWLEDGEMENTS

To Dr Adalbert Laszlo (National Reference Centre for Tuberculosis, Ottawa, Canada), for his revision of the text and suggestions.

linha2.jpg (2100 bytes)

bul1.gif (879 bytes)  REFERENCES

  • Barreto JA, Palaci M, Ferrazoli L, Martins MC, Suleiman L, Lorenco R, Ferreira Jr OC, Riley LW, Johnson Jr WD, Galvão PA 1993. Isolation of Mycobacterium avium complex from bone marrow aspirates of AIDS patients in Brazil. J Infect Dis 68: 777-779.
  •         [ Links ]
  • Elliot AM, Luo N, Tembo G, Halwiindi B, Steebergen G, Machiels L, Pobee J, Nunn P, Hayes RJ, McAdam KPWJ 1990. Impact of HIV on tuberculosis in Zambia: a cross sectional study. BJM 301: 412-415.
  •         [ Links ]
  • Good RC, Snider Jr DE 1983. Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis 146: 829-833.
  •         [ Links ]
  • Grinsztejn B, Fandinho FC, Veloso VG, João EC, Lourenço MC, Nogueira SA, Fonseca LS, Werneck-Barroso E 1997. Mycobacteremia in patients with acquired immunodeficiency syndrome. Arch Intern Med 157: 2359-63.
  •         [ Links ]
  • Horsburgh Jr CR 1991. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Eng J Med 324: 1332-1338.
  •         [ Links ]
  • Hosker HS, Lam CW, Ng Tk, Ma HK, Chan SL 1995. The prevalence and clinical significance of pulmonary infection due to non-tuberculous mycobacteria in Hong Kong. Respir Med 89: 3-8.
  •         [ Links ]
  • Kent PT, Kubica GP 1985. Public health mycobacterio-logy - a guide for level III laboratory. Atlanta: Centers for Disease Control Publication no. PB 86-216546.
  •         [ Links ]
  • Klein NC, Duncanson FP, Lenox TH III, Pitta A, Cohen SC, Wormser GP 1989. Use of mycobacterial smears in the diagnosis of pulmonary tuberculosis in AIDS/ARC patients. Chest 95: 1190-1192.
  •         [ Links ]
  • Kritski AL, Lapa e Silva JR, Conde MB 1998. Tuberculosis and HIV: Renewed challenge. Mem Inst Oswaldo Cruz 93: 417-421.
  •         [ Links ]
  • Kritski AL, Dalcomo MP, del Bianco R, Melo FF, Pinto WP, Schechther M, Castelo A 1995. Associação tuberculose e infecção pelo HIV no Brasil. Bol Of Sanit Panam 118: 542-554.
  •         [ Links ]
  • Murray PR, Elmore C, Krogstad DJ 1980. The acid-fast stain: a specific and predictive test for mycobacterial disease. Ann Intern Med 92: 512-513.
  •         [ Links ]
  • Raviglione MC, Spencer DE, Kochi A 1995. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 273: 220-226.
  •         [ Links ]
  • Shafer RW, Edlin BR 1996. Tuberculosis in patients infected with human immunodeficiency virus: perspective on the past decade. Clin Infect Dis 22: 683-704.
  •         [ Links ]
  • Strumpf IJ, Tsang AY, Sayre JW 1979. Re-evaluation of sputum staining for the diagnosis of pulmonary tuberculosis. Am Rev of Respir Dis 119: 599-602.
  •         [ Links ]
  • Theuer CP, Hopewell PC, Elias D, Schecter GF, Rutherford GW, Chaisson RE 1990. Human immuno-defeciency virus infection in tuberculosis patients. J Infect Dis 162: 8-12.
  •         [ Links ]
  • Toman K 1979. Tuberculosis case finding, p. 6-8. In Tuberculosis Case-finding and Chemotherapy, World Health Organization, Geneva.
  •         [ Links ]
  • WHO 1993. Treatment of Tuberculosis: Guidelines for National Programes, World Health Organization, Geneva, 44 pp.
  •         [ Links ]
  • Yajko DM, Nassos PS, Sanders CA, Madej JJ, Hadley WK 1994. High predictive value of the acid-fast smear for Mycobacterium tuberculosis despite the high prevalence of Mycobacterium avium complex in respiratory specimens. Clin Infect Dis 9: 334-336.
  •         [ Links ]

linha2.jpg (2100 bytes)

TABLE

linha2.jpg (2100 bytes)

This study was supported by International Aids training grant # D43-TW00003 from Fogarty International Center, NIH, USA.

+Corresponding author. Fax: +55-21-550.6903. E-mail: conde@montreal.com.br

Received 13 January 1999

Accepted 7 July 1999

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License